Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II sunitinib study in previously untreated advanced urothelial cancer ineligible for cisplatin
2005-005115-16Phase 2Active
- Sponsor
- Joaquim Bellmunt
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in transitional cell carcinoma (TCC), sponsored by Joaquim Bellmunt. Started Mar 2006; status: active.
02
Drugs
sunitinib
03
Conditions
transitional cell carcinoma (TCC)
Beyond the preview
Go deeper on 2005-005115-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005115-16.